Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Are you more likely to recommend radiation over omission? Whole breast over APBI?
Answer from: Radiation Oncologist at Community Practice
It doesn’t change the recommendation. If adequate, imaging and surgery are done, like any other DCIS.
Sign in or Register to read more
28151
Related Questions
Is re-excision of residual disease ever itself an indication for PMRT?
Under what circumstances would you pursue completion ALND in a patient with multiple positive sentinel nodes after breast-conserving surgery?
What are your top takeaways in Breast Cancer from ESMO 2024?
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
When should the dissected axilla (levels I-II) be included when delivering RNI?
Would you offer prone APBI with IMRT/VMAT?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?